Calithera Biosciences
Patents, Design & Utilities
Last updated:
List of all Calithera Biosciences patents 42 in total
| Status | Patent |
|---|---|
Grant | Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide Filling date: 6 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Solid state forms of fused heteroaromatic pyrrolidinones Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Arginase inhibitor combination therapies Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGY AGENTS Filling date: 6 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: HETEROCYCLIC GLUTAMINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: CONJOINT THERAPY WITH GLUTAMINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Jun 2021 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Combination therapy with glutaminase inhibitors and immuno-oncology agents Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 |
Grant | Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 24 Nov 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Heterocyclic glutaminase inhibitors Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: Ectonucleotidase Inhibitors and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Crystal forms of glutaminase inhibitors Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Application | Utility: Heterocyclic Inhibitors of Glutaminase Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Application | Utility: METHOD OF PREPARING (3R,4S)-3-ACETAMIDO-4-ALLYL-N-(TERT-BUTYL)PYRROLIDINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: Ectonucleotidase Inhibitors and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Grant | Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide Filling date: 6 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: CRYSTAL FORMS OF GLUTAMINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Ectonucleotidase inhibitors and methods of use thereof Filling date: 6 Sep 2025 Issue date: 12 Nov 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY Filling date: 6 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: HETEROCYCLIC INHIBITORS OF GLUTAMINASE Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Treatment of lung cancer with inhibitors of glutaminase Filling date: 6 Sep 2025 Issue date: 15 Oct 2019 |
Application | Utility: COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Grant | Utility: Compositions and methods for inhibiting arginase activity Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Application | Utility: COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGY AGENTS Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 42 of 42 patents.